2. SHARON
BIO-MEDICINE LTD
Sharon Bio-Medicine Limited , Incorporated in 1989.
It is mainly involved in manufacturing of Intermediates, Active
Pharmaceutical Ingredients and Finished Dosage Forms.
Growing at around 50% year on year Sharon now has an annual
turnover of over $100 million.
Recently started an Animal Toxicology Lab Operating as per GLP
requirements.
3. KEY MEMBERS
Mrs. Savita Gowda -MANAGING DIRECTOR.
Mr. Mohan P. Kala -NON EXECUTIVE DIRECTOR.
Mr. Lalit Misra – WHOLE TIME DIRECTOR.
4. Rs. in Lacs
LIQUIDITY RATIO 2010-11 2009-10
Current Ratio=
= 37417.59 = 29020.43
Current Asset 3900.83 3196.65
Current Liabilities
= 9.59:1 = 9.08:1
9.7
9.6
9.5
9.4
9.3
9.2 2010-11
9.1 2009-10
9
8.9
8.8
Current Ratio
5. LIQUIDITY RATIO 2010-11 2009-10
Quick Ratio=
Current Assets – Stock - Prepaid = 21896.22 = 17353.82
expenses 3900.83 3196.65
Current Liabilities - Bank OD
= 5.61:1 = 5.43:1
10
9
8
7
6
5 2010-11
4 2009-10
3
2
1
0
Quick Ratio
6. LIQUIDITY RATIO 2010-11 2009-10
Debtors Turnover Ratio=
Sundry Debtors+ Bills Receivable x 365 = 19,253.50 x 365 = 15,877.20 x
Credit sales 60,604.66 365
49,649.88
= 115.96 days
= 116.72 days
116.8
116.6
116.4
116.2
2010-11
116
2009-10
115.8
115.6
115.4
Debto Turn over Ratio
7. LIQUIDITY RATIO 2010-11 2009-10
Creditors Turnover Ratio=
Sundry Creditors+Bills Payable x = 3235.57 x365 = 2630.44 x365
365 54,334.88 44,609.28
Credit purchases
= 21.74 days = 21.53 days
21.8
21.75
21.7
21.65
21.6 2010-11
21.55 2009-10
21.5
21.45
21.4
Creditors Turnover Ratio
8. LIQUIDITY RATIO 2010-11 2009-10
Inventory holding period=
Inventory x365 = 15,521.37 x 365 = 11,666.61 x 365
Cost of goods sold 50,480.12 41,908.60
= 112.23 days = 101.61 days
114
112
110
108
106
104 2010-11
102 2009-10
100
98
96
Inventory Holding Period
9. SOLVENCY RATIO 2010-11 2009-10
Net Asset Value=
Equity Shareholders fund = 14390.85 = 11495.80
No. of Equity Shares 105.56 105.56
=Rs.136.32 =Rs.108.90
160
140
120
100
80 2010-11
60 2009-10
40
20
0
Net Asset Value